Dr. Timothy Cooper Kunkle is a Chevy Chase, Maryland based Oral and Maxillofacial Surgeon who is specialized in Oral and Maxillofacial Surgery. He does not accept the Medicare-approved amount. Patients will be billed for the treatment. Active license number of Dr. Timothy Cooper Kunkle is 16300 for Oral and Maxillofacial Surgery in Maryland. His current practice location is 5550 Friendship Blvd Ste 250, Chevy Chase. Patients can reach him at 301-652-8555.
Dr. Timothy Cooper Kunkle deals with the diagnosis, surgical and adjunctive treatment of diseases, injuries and defects involving both the functional and esthetic aspects of the hard and soft tissues of the oral and maxillofacial region.
Complete Profile:
Dr. Timothy Cooper Kunkle speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1295000156
NPI Enumeration Date:
12 Mar, 2012
NPI Last Update On:
14 Jun, 2018
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Timothy Cooper Kunkle are as mentioned below.
License Number
Specialization
State
Status
16300
Oral and Maxillofacial Surgery
Maryland
Primary
DEN1001836
Oral and Maxillofacial Surgery
District Of Columbia
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Patients can reach Dr. Timothy Cooper Kunkle at 5550 Friendship Blvd Ste 250, Chevy Chase, Maryland or can call to book an appointment on 301-652-8555. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 October, 2024.